Oral Solid Dosage Pharmaceutical Formulation Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the oral solid dosage pharmaceutical formulation market?
In recent times, the market size for oral solid dosage pharmaceutical formulation has seen robust growth. The market is expected to expand from $618.34 billion in 2024 to $659.54 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth during the historic period can be linked to factors like the rising prevalence of chronic diseases, an aging population, expanded access to healthcare services, the promotion of generic formulations, and a shift in consumer preference.
What will be the oral solid dosage pharmaceutical formulation market size in the future?
The market for oral solid dosage pharmaceutical formulations is predicted to experience robust expansion in the upcoming years, reaching a value of $842.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. This projected growth through the forecast period is anticipated to be driven by factors such as the increasing demand for personalized medicine, the embracing of controlled-release mechanisms, concentration on biopharmaceuticals, expansion into emerging markets, and alterations in policy and reimbursement. Key trends expected during this period comprise the adoption of personalized medicine, integration of digital health, growing prominence of telemedicine services, emphasis on preventive healthcare, and the continued penetration of artificial intelligence in the healthcare domain.
Get your oral solid dosage pharmaceutical formulation market report here!
What main drivers are fueling expansion in the oral solid dosage pharmaceutical formulation market?
The rise in number of chronic disease cases is anticipated to fuel the expansion of the oral solid dosage pharmaceutical formulation market. Chronic diseases are enduring health conditions that typically persist for three months or longer. The escalation of chronic diseases can be attributed to an aging population, inactive lifestyles, poor eating habits, environmental factors, and advancements in detection and diagnostic procedures. Oral solid dosage pharmaceutical formulations—known for their convenience, stability, and precise dosages—are crucial to managing chronic diseases and promoting long-term treatment adherence. For example, the World Health Organization, a Switzerland based international organization, projected in February 2024 that over 35 million new cancer cases would emerge by 2050, a 77% surge compared to the estimated 20 million cases in 2022. The growing prevalence of chronic diseases is therefore a key driver of growth for the oral solid dosage pharmaceutical formulation market.
What key areas define the segmentation of the global oral solid dosage pharmaceutical formulation market?
The oral solid dosage pharmaceutical formulation market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles, Gummies
2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets
4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Controlled-Release Tablets, Effervescent Tablets, Chewable Tablets, Sublingual Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules
3) By Powders And Granules: Oral Powders (Reconstitution), Granules (Oral Suspension Or Dispersible Granules)
4) By Lozenges And Pastilles: Medicinal Lozenges, Herbal Lozenges, Sugar-Free Lozenges, Pastilles ( Throat Or Cough Relief)
5) By Gummies: Vitamin Gummies, Herbal And Nutritional Supplement Gummies, Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15626&type=smp
Who are the dominant players expanding their reach in the oral solid dosage pharmaceutical formulation market?
Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International
What emerging trends are influencing the growth of the oral solid dosage pharmaceutical formulation market?
Leading firms in the oral solid dosage pharmaceutical formulation market are focusing on creating innovative products like liquid-filled capsules to boost drug delivery, enhance bioavailability, and provide easier dosing options for patients. These capsules contain a gelatin shell filled with a liquid or semi-solid preparation that includes active pharmaceutical ingredients (APIs) and excipients. For example, Zeon Lifesciences Ltd, a pharmaceutical company based in India, in July 2023, introduced liquid-filled capsules that employ a sophisticated delivery system that improves bioavailability and absorption speed. These capsules guarantee potent concentration levels of active ingredients for superior efficacy and immediate impact. Zeon’s liquid-filled capsules deliver accurate and consistent dosages, enhancing patient adherence and management over medication execution. They make use of advanced methods to boost bioavailability, better patient results, and maintain the medication’s integrity. Zeon’s liquid-filled capsules serve as a convenient, effective, and dependable replacement to traditional dosage forms, establishing a fresh paradigm for patient treatment and adherence in the pharmaceutical sector.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15626
Which regions are emerging as leaders in the oral solid dosage pharmaceutical formulation market?
North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Oral Biologics & Biosimilars Global Market Report 2024
Oral Care Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report
Intraoral Cameras Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intraoral-cameras-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
